In this Issue:
Validated risk score for predicting clinical outcome
Viral BCP mutant linked to liver cirrhosis in HBV
MDA5 plays an important role in HCV defence
New HCV intergenotypic recombinant genotype 2/1 viruses
Cultured HLSECs mediate immunity against HCV
Treating HCV genotype 1 patients after failing PegIFN/ribavirin
IFN-free regimen for genotype 1b chronic HCV infection
Adding a PI increases infection rates in HCV-related cirrhosis
MTC HBV transmission among women with high HBV DNA
The TMPRSS2 gene activates HCV infection
Please login below to download this issue (PDF)